Outcome without any adjuvant systemic treatment in stage I ER+/HER2− breast cancer patients included in the MINDACT trial
| Autor: | Lopes Cardozo, J.M.N., Byng, D., Drukker, C.A., Schmidt, M.K., Binuya, M.A., van ’t Veer, L.J., Cardoso, F., Piccart, M., Smorenburg, C.H., Poncet, C., Rutgers, E.J.T. |
|---|---|
| Zdroj: | In Annals of Oncology March 2022 33(3):310-320 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|